Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From wind to seismic signature captured by seismometers in lake Lucerne.

Scientific reports·2025
Same author

Implementation and outcome of personalized treatment strategies in advanced genitourinary cancers.

ESMO open·2025
Same author

Impact of peritoneal bladder flap in robot-assisted radical prostatectomy patients on lymphoceles: a prospective randomised trial.

World journal of urology·2025
Same author

[The interoperability of IIEF-5 with EPIC-26 : Sexual function after radical prostatectomy].

Urologie (Heidelberg, Germany)·2023
Same author

[Metachronous oligometastatic prostate cancer-the more the better or only local treatment?]

Der Urologe. Ausg. A·2021
Same author

Aktuelle Urologie·2021

Related Experiment Video

Updated: May 2, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.1K

[Current results on PSA-based prostate cancer detection].

M Graefen1, T Schlomm, T Steuber

  • 1Martini-Klinik, Prostatakarzinomzentrum am UKE, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland.

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|February 25, 2014
PubMed
Summary

Prostate-specific antigen (PSA) testing aids early prostate cancer detection but risks over-treatment. Reliable stratification of indolent tumors is crucial for active surveillance and reducing unnecessary interventions.

More Related Videos

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.4K
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.6K

Related Experiment Videos

Last Updated: May 2, 2026

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

2.1K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:05

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

1.4K
Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance
05:35

Transperineal Prostate Biopsy Using a Cone-shaped Double-hole Method with Dual-plane Probe Guidance

Published on: June 6, 2025

2.6K

Area of Science:

  • Oncology
  • Urology

Context:

  • Prostate cancer is a leading cause of cancer death in Western countries.
  • Prostate-specific antigen (PSA) blood tests facilitate early detection, reducing mortality.
  • However, PSA screening can lead to over-detection and over-treatment of indolent tumors.

Purpose:

  • To highlight the critical need for improved risk stratification in active surveillance programs for early-diagnosed prostate cancers.
  • To discuss the expansion of PSA screening alongside better risk stratification strategies.

Summary:

  • Early prostate cancer detection via PSA testing reduces mortality but increases the risk of overtreatment for indolent tumors.
  • Effective stratification of indolent tumors within active surveillance programs is essential to mitigate overtreatment.
  • Expanding PSA screening requires concurrent advancements in risk stratification to minimize palliative treatments, metastases, and deaths.

Impact:

  • Aims to reduce overtreatment and associated complications in early prostate cancer management.
  • Supports informed decision-making for clinicians and patients regarding PSA screening and active surveillance.
  • Contributes to lowering prostate cancer-specific mortality and improving patient outcomes through optimized diagnostic and treatment pathways.